Project Grant K24DA061976
Award Date
1/1/25
Completion Date
12/31/29
Dollars Obligated
$209K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Belmont, MA 02478, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $425,636 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), over a 5-year period from September 30, 2024 to July 31, 2029. The primary purpose of this award is to support a mentorship program led by an experienced HIV and substance use researcher at MGH. The mentoring will focus on training pre- and...
This Project Grant award of $207,910 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports a 3-year training program for the development of an academic career in psychiatric disease research. The award recipient, a graduate student at the University of Michigan, will pursue research focused on understanding the contribution of pathway-specific neural activity to individual and sex differences in the attribution of salience to...
The National Institute on Drug Abuse (NIDA) awarded a $264,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Innovation Research And Training, Inc. (IRT), a woman-owned small business research organization based in Durham, North Carolina. The purpose of this 3-year project, beginning September 2024, is to evaluate the "Substance of Change: Building Assets in Mentees Affected by Substance Misuse" (SOC), an interactive, multimedia, web-based,...
The National Institute of Mental Health (NIMH) awarded a 4-year, $213,369 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to support mentoring activities and patient-oriented research (POR) on suicide risk processes among youth and young adults. The funding will provide the Principal Investigator, a clinical psychologist at MGH and Harvard Medical School, with 30% protected time to expand...
This $181,040 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to create an immersive training experience to study the genetic etiology of substance use disorders (SUDs). The award recipient, Yale University, will leverage the Million Veteran Program (MVP) biobank to: (1) model patterns of SUD co-occurrence and substance co-use, (2) utilize electronic health record data and toxicology results to provide...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research into the neural circuitry underlying goal-directed and habit learning behaviors. The $162,672 award, with a performance period from August 1, 2024 to March 31, 2028, will be used by the University of California, Los Angeles (UCLA) to conduct an in-depth investigation of the role of dopaminergic projections to the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $196,560 to the Regents of the University of Michigan to conduct research on the neural correlates of reward and threat processing in adolescents with a history of childhood trauma. The overarching goals are to: 1) identify multivariate neuroimaging signatures predictive of problematic substance use, 2) elucidate how different types of...
This $118,656 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to investigate the neurophysiological mechanisms by which trauma and cocaine exposure influence drug-seeking behavior in male and female rats. The research aims to dissect how traumatic experiences and cocaine use alter communication between the prelimbic cortex and nucleus accumbens core, with the goal of providing insight into the...
This $155,140 K01 research project grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to advance understanding of the relationships between substance use disorders (SUDs) and other forms of psychopathology. The grant recipient, Rutgers The State University of New Jersey, will use advanced quantitative and statistical genetics methods to model the phenotypic and genetic overlap between SUDs and other psychiatric...